Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma

Clinical trial NCT07463599 · RECRUITING

Trial details

NCT number: NCT07463599
Sponsor: HonorHealth Research Institute
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Carcinoma (mCRC)Colorectal Cancer (CRC)Adenomatous Polyposis Coli (APC) Gene Mutation Catenin Beta-1 (CTNNB1) Gene Mutation

Start date: 2026-02-17
Primary completion: 2029-01-01
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.